Abstract:BACKGROUND:Retinoblastoma protein-interacting zinc-finger gene 1 (RIZ1) displays strong tumor suppressive activities, and its expression is often silenced in many types of human tumors. However, the relationship between RIZ1 expression and glioma prognosis remains unclear.METHODS:The dysregulation of RIZ1 was evaluated using real-time polymerase chain reaction, western blot, and immunohistochemical analysis of gliomas from 51 patients. Correlation analysis was performed to examine relationships between RIZ1 immunoreactivity, clinicopathological features, and patient prognosis. Also, human malignant glioma U87 and U251 cell lines were stably transduced with ectogenic RIZ1 using a lentiviral vector to investigate the effects of induced expression of RIZ1 on cell proliferation, cell cycle, and apoptosis.RESULTS:Real-time polymerase chain reaction and western blot analysis showed that RIZ1 was downregulated in high-grade gliomas compared with low-grade gliomas and normal brain tissue. Immunohistochemistry showed less RIZ1 labeling in high-grade gliomas than in low-grade gliomas. There was a negative correlation between RIZ1 and Ki-67 immunoreactivity. Clinicopathological evaluation revealed that RIZ1 expression was negatively correlated with tumor grade and patient age. Kaplan-Meier survival analysis showed a positive correlation between RIZ1 immunoreactivity level and progression-free and overall survival times. Multivariate analysis showed that high RIZ1 expression was an independent prognostic factor for patients with gliomas. Induced expression of RIZ1 in U87 and U251 cells reduced cell proliferation and increased apoptosis, and cell cycle analysis revealed that a majority of cells were arrested at G2-M. Moreover, transfection with a RIZ1 expression vector increased p53 and caspase-3 expression and decreased p-IKBα and p-AKT protein levels, suggesting that RIZ1 may stimulate p53-mediated apoptosis and inhibit p-IKBα and p-AKT signaling pathways.CONCLUSIONS:Our results suggest that high RIZ1 labeling is indicative of lower grades of gliomas and is associated with better progression-free and overall survival rates. Therefore, RIZ1 may be a promising therapeutic target for patients with gliomas.

RIZ1: a Potential Tumor Suppressor in Glioma

Polymeric Immunoglobulin Receptor Expression is Predictive of Poor Prognosis in Glioma Patients.

Methylation Status of the Riz1 Gene Promoter in Human Glioma Tissues and Cell Lines

The transducible TAT-RIZ1-PR protein exerts histone methyltransferase activity and tumor-suppressive functions in human malignant meningiomas.

Tumor Formation And Inactivation Of Riz1, An Rb-Binding Member Of A Nuclear Protein-Methyltransferase Superfamily

Increased RLIP76 Expression in IDH1 Wild‑type Glioblastoma Multiforme is Associated with Worse Prognosis

RLIP76 is Overexpressed in Human Glioblastomas and is Required for Proliferation, Tumorigenesis and Suppression of Apoptosis.

LZTR1 inactivation promotes MAPK/ ERK pathway activation in glioblastoma by stabilizing oncoprotein RIT1

RIT1 Promotes Glioma Proliferation and Invasion via the AKT/ERK/NF-ĸB Signaling Pathway

RAB1A Regulates Glioma Cellular Proliferation and Invasion Via the Mtor Signaling Pathway and Epithelial-Mesenchymal Transition.

Silencing Myelin Protein Zero-Like 1 Expression Suppresses Cell Proliferation and Invasiveness of Human Glioma Cells by Inhibiting Multiple Cancer-Associated Signal Pathways

Aberrant Methylation of the 1p36 Tumor Suppressor Gene RIZ1 in Renal Cell Carcinoma.

The Unusual Yin-Yang Fashion of RIZ1/RIZ2 Contributes to the Progression of Esophageal Squamous Cell Carcinoma

ZEB1 expression is increased in IDH1- mutant lower-grade gliomas

IDH1 mutation decreases the invasiveness of glioma by downregulating the expression and activity of TAZ

CS-27 * IDH1/2 MUTATIONS INFLUENCE ZEB1 EXPRESSION IN GRADES II AND III GLIOMAS

RIT1 Promotes Glioma Proliferation and Invasion via the NF-ĸB/p65 pathway

Retinoblastoma Protein- interacting Zinc Finger Gene 1 Expression in Human Esophageal Squamous Cell Carcinoma

MiRNA203 Suppresses the Expression of Protumorigenic STAT1 in Glioblastoma to Inhibit Tumorigenesis

A Role for LRIG1 in the Regulation of Malignant Glioma Aggressiveness.

A Long Noncoding Rna Zeb1-As1 Promotes Tumorigenesis and Predicts Poor Prognosis in Glioma